Form 4 for CHRS Coherus Oncology, Inc.
Accepted 2023-01-12 00:00:00 ET · period of report 2023-01-10 · accession 0001567619-23-000892 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2023-01-12 | 2023-01-10+ | CHRS | Vexler Vladimir | CSO | F - Tax | $10.05 | -7,204 | 94.9K | -7% | -$72.4K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-01-11 | F | D | 3,602 | $10.26 | 91,323 | D | — | — | (F1) Represents shares automatically withheld to pay related tax liability in connection with the vesting of restricted stock units in accordance with Rule 16b-3. |
| 2 | Common | Common Stock | 2023-01-10 | F | D | 3,602 | $9.85 | 94,925 | D | — | — | (F1) Represents shares automatically withheld to pay related tax liability in connection with the vesting of restricted stock units in accordance with Rule 16b-3. |